7 months on Fin (0,5mg) and Min (2,5mg) 8/16/2026
The user experienced significant hair regrowth and improved hairline after 7 months on finasteride (0.5mg) and minoxidil (2.5mg). They reported minor side effects, such as nipple sensitivity, but no swelling in feet or legs.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Hair regrowth after 2 years of finasteride
A user shared their positive experience with hair regrowth after two years of using finasteride, reporting no side effects. Other users discussed their experiences, including side effects like gynecomastia, and shared advice on managing potential risks.
community Finasteride is saving me!!! 1 yr results
A 25-year-old male experienced significant hair regrowth after one year of using 0.5mg daily finasteride, with plans to add 1.25mg oral minoxidil and microneedling for further improvement. He also uses Nizoral shampoo weekly and reports no current side effects.
community Finasteride is ****ing magical
Finasteride has led to significant hair regrowth for some users, with noticeable improvements in two months, but side effects like erectile dysfunction have caused some to stop using it. Some users combine finasteride with minoxidil and other supplements, despite concerns about side effects.
community My first 8 months and prgress so far, min + fin.
The user started experiencing hair loss at 26 and began treatment with topical minoxidil and oral finasteride. After 8 months, they noticed hair regrowth, especially baby hairs, and remain hopeful for further improvement.
community How is there zero improvement with finding the cure?
Hair loss treatments have not advanced since 2018, with finasteride, minoxidil, and RU58841 still being the main options. A permanent cure is unlikely due to the profitability of ongoing treatments.
Related Research
6 / 6 resultsresearch Interventions for androgenic alopecia in women
This protocol outlines a planned Cochrane Review to evaluate the effectiveness and safety of treatment options for androgenic alopecia in women, without reporting new findings yet.
research Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
This case series suggests that EE/CMA 0.03mg/2mg may help manage dermatological disorders related to androgen excess, as evidenced by symptomatic improvements in the four patients treated.
research Interventions for androgenic alopecia in women
This protocol outlines a planned Cochrane Review assessing the effectiveness and safety of treatments for androgenic alopecia in women, reporting no new research findings.
research Dermatologic Manifestations of Polycystic Ovary Syndrome
This review discusses the dermatologic features of PCOS as potential early indicators of the syndrome and notes that treatment of these conditions may enhance quality of life and psychological well-being, but it reports no new clinical results.
research Male androgenetic alopecia (Part II)
This article reviews treatment options for male androgenetic alopecia, including their distinct aims of arresting progression, stimulating regrowth, and concealing hair loss, and reports no new clinical results.
research Scalp micropigmentation: a promising camouflage modality
This narrative review reports that scalp micropigmentation offers immediate cosmetic improvements in hair density appearance, but does not promote actual hair regrowth and results vary based on the operator's skill.